Business Summary
Xellia Pharmaceuticals AS is a Norway-based pharmaceutical company. It provides anti-infective treatments against serious and life-threatening infections. It operates as a developer, manufacturer and trusted supplier of fermented and semi-synthetic active pharmaceutical ingredients (APIs) and finished dosage forms (FDF), and supplies Vancomycin and Colistimethane Sodium (CMS). Its anti-infective treatments target bacterial and antibiotic-resistant infections and fungal diseases. Additionally, it is engaged in the development of delivery systems.
Country of Incorporation
Norway
Incorporation Date
1995-03-12
Business Sector
Pharmaceuticals & Medical Research
Company Address
Silurveien 2